Search

everythinglearnresearchcommunity

for

Search:↓

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

The document concludes that HAIR-AN syndrome should be considered when a patient shows severe hyperandrogenism and insulin resistance after excluding tumors.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Both HLA-B and MICA are independently linked to alopecia areata.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Isoalantolactone promotes hair growth by activating specific cell pathways.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Apremilast may help treat hair loss in alopecia areata.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

The IBHRS is now operational.